Insider buying last 90 days
No open-market insider purchases were filed for UBS in the last 90 days.
From Form 4 filings, dated to when each was filed.
This week's headlines around UBS are largely ownership and conference-related rather than operational: filings disclosing passive stakes or voting-rights thresholds in companies such as Summit Hotel Properties, Mayfield Group Holdings and Delivery Hero, alongside a string of healthcare and biopharma companies announcing they will present at the UBS Global Healthcare Conference and UBS Global Biopharma Conference. None of these items speak directly to UBS's own results, guidance or regulatory standing; they are disclosure and conference-participation notices involving UBS as counterparty or host.
UBS shares closed at $50.67, up 5.6%, sitting above both the 50-day average of $49.94 and the 200-day average of $47.11, with the shorter average also above the longer one. The one-month return is 4.5%, the three-month return is -4.1%, and the one-year return is 33.4%, against a 52-week range of $36.30 to $55.99. The GekkoIndex reads 52, placing it in the Neutral zone, down from a higher reading five days prior. Gekko Fair Value stands at $52.09, putting the current price 2.7% below that level.
The next earnings date falls on 3 February 2027, before the open, which sits 90 days out and beyond a typical 20-trading-day holding window. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows, though one billionaire holder is recorded. Seasonally, the next 20 trading days have averaged a 6.5% return over five years, rising in 4 of those years. The consensus analyst target stands at $55.20.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
UBS scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $50.67 is above the 50-day ($49.94) and 200-day ($47.11) averages, and the 50-day is above the 200-day.
See the chart52, Neutral
Reading 52 is in the Neutral zone.
See the GekkoIndex2.7% below
Price is within 5% of Gekko Fair Value (2.7% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 90 days
Next report Feb 3, 2027, 90 days away — outside a typical 20-trading-day hold.
See earnings+6.5% on average
From this point in the calendar, the next 20 trading days averaged +6.5% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
UBS closed at $50.67 on Nov 4, 2026, +33.4% over the past year, inside a 52-week range of $36.30 to $55.99.
Use the left and right arrow keys to read daily values.
Put UBS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
UBS offers a broad set of financial services to individuals, businesses and institutions across the globe, ranging from personal advice to large scale market transactions. The firm has built its reputation on guiding wealthy and ultra-wealthy clients through investment, lending and long term planning decisions.
Its work is split into four main areas. Global Wealth Management focuses on affluent and ultra-high-net-worth individuals, offering investment advice, mortgages and securities-based loans, along with estate planning, philanthropic guidance and family office support. Personal & Corporate Banking serves everyday customers with deposits, cards and digital banking tools while also giving corporate and institutional clients access to equity and debt financing, credit facilities, trade finance, custody and payment services. Asset Management builds portfolios spanning equities, bonds, hedge funds, real estate and private assets, and designs multi-asset and advisory solutions for institutional investors. The Investment Bank advises companies on major transactions and fundraising, executes trading and financing of securities in global markets, and supports clients with risk management and market research.
UBS is headquartered in Zurich, Switzerland, and dates back to 1862, having traded for years as UBS AG before renaming itself in December 2014. Its stock trades on the NYSE under the ticker UBS.
UBS’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52, in the Neutral zone, down 14 points over five sessions.
Down 14 points over five sessions, from the Accumulation zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 42 | +1.4% | +5.2% | ||
| Accumulation | 173 | +0.3% | +4.2% | ||
| Neutral (current zone) | 430 | +0.4% | +0.8% | ||
| Distribution | 51 | +0.1% | +0.5% | ||
| Selling | 1 | Too few readings yet | |||
Average UBS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
UBS trades 2.7% below Gekko Fair Value of $52.09, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what UBS shares are worth, recalculated every trading day.
$52.09
Gekko Fair Value, Nov 4, 2026
2.7% below fair value · About fair value
At the end of Aug 2026 the price was 2.9% above the estimate.
No open-market insider purchases were filed for UBS, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for UBS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in UBS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
UBS has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds UBS.
UBS reports on Feb 3, 2027, before the open (90 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 3, 2027
Expected before the open, 90 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.87 est $0.90 | $13.35B est $13.40B | +2.6% |
| Apr 29, 2026 | $0.95 est $0.83 | $13.64B est $13.16B | +4.3% |
| Feb 4, 2026 | $0.67 est $0.53 | $12.20B est $11.71B | −8.2% |
| Oct 29, 2025 | $0.76 est $0.49 | $12.20B est $11.92B | −2.7% |
| Jul 30, 2025 | $0.82 est $0.92 | $18.32B est $9.53B | −1.8% |
| Apr 30, 2025 | $0.51 est $0.42 | $10.94B est $9.61B | −1.2% |
| Feb 4, 2025 | $0.39 est $0.34 | $10.56B est $10.90B | −6.7% |
| Oct 30, 2024 | $0.53 est $0.37 | $10.96B est $10.90B | −6.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for UBS is $55.20, +8.9% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, UBS averaged +6.5% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.3% | 4 of 5 |
| Next 10 trading days | +4.1% | 4 of 5 |
| Next 15 trading days | +2.6% | 3 of 5 |
| Next 20 trading days | +6.5% | 4 of 5 |
| Next 30 trading days | +8.7% | 4 of 5 |
For scale, UBS’s typical 20-trading-day move in either direction is about 6%.
UBS’s market cap is $155.1B, with a P/E ratio of 16 and revenue of $53.52B over the last twelve months.
Coverage of UBS this week reads positive: 6 positive, 5 neutral and 1 negative headlines.
UBS’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSMorgan Stanley | Neutral | 4.3% below |
| BLKBlackRock | Neutral | 1.5% above |
| BXBlackstone | Neutral | 2.3% below |
| BNBrookfield | Distribution | 3.0% below |
| KKRKKR | Neutral | 4.6% below |
| BAMBrookfield Asset Management | Distribution | 6.9% above |
A peer links to its own page where one exists.
UBS’s market cap is $155.1B at the Nov 4, 2026 close of $50.67, with 3.03B shares outstanding. The shares trade on a P/E ratio of 16.
The consensus analyst 12-month price target for UBS is $55.20, +8.9% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate UBS is about fair value: the Nov 4, 2026 close of $50.67 is 2.7% below Gekko Fair Value of $52.09. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
UBS is expected to report on Feb 3, 2027, before the market opens (90 days away). Analysts expect earnings of $0.90 per share on revenue of $13.00B. UBS beat the earnings estimate in 6 of its last 8 reports, moving 4.3% on average across the report.
UBS’s 52-week high is $55.99 and its 52-week low is $36.30; it closed at $50.67 on Nov 4, 2026, +33.4% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.